Evidence map›Paper›PMID 40103724›Full record

ReviewChemical science2025

Advancements and prospects for eco-friendly, high-performance silver bismuth halide solar cells.

Natalia Belen Correa Guerrero, M Dolores Perez, Naoyuki Shibayama, Tsutomu Miyasaka

Abstract readReview
In one paragraph

Review in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natalia Belen Correa GuerreroToin University of Yokohama 1614 Kurogane-cho, Aoba Yokohama Kanagawa Japan shibayama@toin.ac.jp miyasaka@toin.ac.jp.ORCID https://orcid.org/0000-0002-9196-3317
M Dolores PerezDepto. Física Materia Condensada (GIyA), Instituto de Nanociencia y Nanotecnología (CONICET), CNEA, Centro Atómico Constituyentes Avda. Gral. Paz 1499, San Martín 1650 Buenos Aires Argentina mdperez@unsam.edu.ar.ORCID https://orcid.org/0000-0002-5640-8289
Naoyuki ShibayamaToin University of Yokohama 1614 Kurogane-cho, Aoba Yokohama Kanagawa Japan shibayama@toin.ac.jp miyasaka@toin.ac.jp.ORCID https://orcid.org/0000-0003-2182-049X
Tsutomu MiyasakaToin University of Yokohama 1614 Kurogane-cho, Aoba Yokohama Kanagawa Japan shibayama@toin.ac.jp miyasaka@toin.ac.jp.ORCID https://orcid.org/0000-0001-8535-7911

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demand for lead-free alternatives to lead-halide perovskite (LHP) solar cells has prompted extensive research efforts to explore alternative materials. Silver bismuth iodide (Ag-Bi-I) absorbers have an appropriate band gap between 1.8 and 1.9 eV for solar cells and exhibit a high absorption coefficient and excellent stability under ambient conditions. However, achieving sufficient power conversion efficiency (PCE) at the lab scale. The maximum PCE reported to date for Ag-Bi-I (SBI) materials is 5.56%, a much lower PCE value than those obtained for LHP based solar cells. Various approaches have been employed to improve the properties of SBI-based solar cells, including solution engineering, additive incorporation, and cation exchange. However, trap-assisted recombination and intrinsic limitations may be the underlying factors impacting their efficiency. With an overview of previous research efforts on SBI materials, we highlight different approaches for PCE enhancement and discuss the current state of basic research on material preparation and analysis. Furthermore, this study offers insights and prospects for SBI as a material for solar energy applications.

Identifiers

PMID40103724
PMCPMC11912501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.